Regional nodal irradiation in the conservative treatment of breast cancer
- 1 October 1990
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 19 (4), 859-865
- https://doi.org/10.1016/0360-3016(90)90005-5
Abstract
At this institution conservative treatment of breast cancer was begun in the 1960's. The following analysis represents our experience through 1984 with specific reference to the management of the regional lymph nodes. A total of 432 patients with clinical stage I and II breast cancer were treated between 1962 and 1984 with lumpectomy and radiation therapy. The breast was treated with tangential fields to a median dose of 4800 cGy and electron conedown to a total tumor bed dose of 6400 cGy. Axillary dissection was not routinely performed, particularly in the earlier years. More recently, axillary dissection has been used with increasing frequency if it was felt that the results of the dissection would influence systemic treatment. One hundred eighty-seven patients (43%) underwent axillary dissection (30% pathologically positive) and routinely received regional nodal irradiation (median dose 4600 cGy) to the internal mammary and supraclavicular lymph nodes. Two hundred forty-five patients (57%) did not undergo axillary dissection and routinely received regional nodal irradiation to the internal mammary, supraclavicular, and entire axillary regions to a total median dose of 4600 cGy. As of May 1989 with a median follow-up of 7.5 years, there have been a total of 12 nodal failures for an actuarial nodal control rate of 97% at 5 years and 96% at 10 years. The actuarial 5-year regional nodal control rate was the same for both the group of patients receiving regional RT alone without axillary dissection and the group of patients receiving axillary dissection and supraclavicular/internal mammary radiation. There has been minimal morbidity associated with this treatment policy. We conclude that regional nodal irradiation as described above, with or without axillary dissection, results in a high rate of regional nodal control and minimal treatment morbidity in patients undergoing conservative treatment of early stage breast cancer.Keywords
This publication has 14 references indexed in Scilit:
- Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- The Impact of tumor size and histology on local control after breast-conserving therapyRadiotherapy and Oncology, 1988
- Management of the axilla in conservatively treated breast cancer: 592 Patients treated at institut Gustave-RoussyInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Postoperative radiotherapy in breast cancer—long-term results from the Oslo studyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985
- Conservative treatment of early carcinoma of the breast: Significance of axillary dissection and iridium implantRadiotherapy and Oncology, 1985
- Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-RoussyInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Reflections on breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1976